Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients

被引:12
作者
Araujo-Castro, Marta [1 ]
Pascual-Corrales, Eider [1 ]
Acitores Cancela, Alberto [2 ]
Garcia Duque, Sara [3 ]
Ley Urzaiz, Luis [2 ]
Rodriguez Berrocal, Victor [2 ,3 ]
机构
[1] Hosp Univ Ramon y Cajal, Inst Invest Biomed Ramon y Cajal IRYCIS, Dept Endocrinol & Nutr, Neuroendocrinol Unit, Madrid, Spain
[2] Hosp Univ Ramon y Cajal, Dept Neurosurg, Pituitary Surg Unit, Madrid, Spain
[3] Hosp Univ HM Puerta del Sur, Dept Neurosurg, Endoscop Skull Base Unit, Madrid, Spain
关键词
Pituitary adenomas; Anterior pituitary function; Hypopituitarism; Panhypopituitarism; Anterior pituitary dysfunction; TRANSSPHENOIDAL SURGERY; DIAGNOSIS; ADULTS; HYPOPITUITARISM; HYPERPROLACTINEMIA; CLASSIFICATION; EPIDEMIOLOGY; GH;
D O I
10.1007/s12020-020-02455-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To investigate the status of preoperative anterior pituitary function in patients undergoing pituitary adenoma (PA) resection and to identify factors associated with preoperative anterior pituitary dysfunction (APD). Methods Patients with functioning and nonfunctioning PAs who underwent pituitary adenoma resection for first time, from January 2009 to December 2019 were analyzed. Results Total sample included 232 patients; 123 (53.2%) females, mean age at diagnosis was 53.3 years. Sixty-three percent presented as nonfunctioning PAs and 37.1% as functioning PAs. Eighty-eight percent were macroadenomas and 34.9% had cavernous sinus invasion. APD was demonstrated in 36.2% (n = 84) of the patients. The FSH/LH deficit was the most frequent anterior pituitary deficit (31.9%); followed by ACTH (18.1%); TSH (16.4%) and GH (13.8%). We identified as independent risk factors of APD, male sex (OR = 6.1, 95% CI = 3.3-11.0); age (OR = 1.03 for each year, 95% CI = 1.01-1.04), diabetes mellitus (OR = 3.5, 95% CI = 1.63-7.69), pituitary apoplexy presentation (OR = 4.3, 95% CI = 1.3-14.5) and tumor size (OR = 1.06 for each mm, 95% CI = 1.04-1.09). Nonfunctioning PAs (NFPA) had higher risk of APD than functioning PAs (FPA) (OR = 2.8 (95% CI = 1.5-5.0), but these differences disappeared after adjusted by tumor size (OR adjusted by tumor size = 1.7, 95% CI = 0.9-3.3). The tumor size with the highest diagnostic accuracy to predict hypopituitarism was 22 mm (sensitivity of 61.9% and specificity of 70.1%). Conclusion More than one third of PAs candidates for surgery had APD. The male sex, diabetes, an older age, pituitary apoplexy, and larger PAs were risk factors of APD. Hence, in these patients, the hormonal study should be prioritized and the need for dynamic tests must be carefully assessed.
引用
收藏
页码:584 / 592
页数:9
相关论文
共 47 条
  • [1] Epidemiology and etiopathogenesis of pituitary adenomas
    Aflorei, Elena D.
    Korbonits, Marta
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (03) : 379 - 394
  • [2] Experience in management of 51 non-functioning pituitary adenomas:: Indications for post-operative radiotherapy
    Alameda, C
    Lucas, T
    Pineda, E
    Brito, M
    Uría, JG
    Magallón, R
    Estrada, J
    Barceló, B
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (01) : 18 - 22
  • [3] Management of Hypopituitarism
    Alexandraki, Krystallenia, I
    Grossman, Ashley B.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [4] Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus
    Alkemade, A
    Unmehopa, UA
    Wiersinga, WM
    Swaab, DF
    Fliers, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) : 323 - 327
  • [5] The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas
    Arafah, BM
    Prunty, D
    Ybarra, J
    Hlavin, ML
    Selman, WR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) : 1789 - 1793
  • [6] Postoperative management of patients with pituitary tumors submitted to pituitary surgery. Experience of a Spanish Pituitary Tumor Center of Excellence
    Araujo-Castro, M.
    Pascual-Corrales, E.
    San Millan, J. S. Martinez
    Rebolleda, G.
    Pian, H.
    Ruz-Caracuel, I.
    Granados, G. De Los Santos
    Urzaiz, L. Ley
    Escobar-Morreale, H. F.
    Berrocal, V. Rodriguez
    [J]. ENDOCRINE, 2020, 69 (01) : 5 - 17
  • [7] Pituitary tumors: epidemiology and clinical presentation spectrum
    Araujo-Castro, Marta
    Rodriguez Berrocal, Victor
    Pascual-Corrales, Eider
    [J]. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (02): : 145 - 155
  • [8] Phenotype and resistance patterns of 10 resistant prolactinomas
    Araujo-Castro, Marta
    Abad Lopez, Ainhoa
    Aller Pardo, Javier
    Kanaan Kanaan, Laura
    Palacios Garcia, Nuria
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2020, 67 (03): : 194 - 204
  • [9] 2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors
    Beck-Peccoz, P.
    Lania, A.
    Beckers, A.
    Chatterjee, K.
    Wemeau, J. -L.
    [J]. EUROPEAN THYROID JOURNAL, 2013, 2 (02) : 76 - 82
  • [10] Estrogen receptors in human pituitary tumors
    Burdman, J. A.
    Pauni, M.
    Heredia Sereno, G. M.
    Bordon, A. E.
    [J]. HORMONE AND METABOLIC RESEARCH, 2008, 40 (08) : 524 - 527